The new N1 system marks the next step in the latest wave of innovation coming from Nobel Biocare, which began with the introduction of the XealTM and TiUltraTM surfaces for abutments and implants at the International Dental Show in Cologne in Germany. Both surfaces will be also available on the new system, which is planned for release in CE markets in fall 2019. Dental professionals who want a pre-launch experience with this step forward in implant dentistry are strongly advised to register for the Nobel Biocare Global Symposium in Madrid in order to secure their seat for this landmark dental event.
One of three global meetings to be held over the next three years, the symposium in Madrid will host over 60 internationally acclaimed experts of whom several will, among other important advancements in implant dentistry, share their experience with the N1 system. From enhancing esthetics and improving long-term clinical outcomes to implementing a fully integrated digital workflow, participants will have plenty to learn and discover about how to bring their clinical skills to the next level. A number of special hands-on workshops will further show them how to best implement the latest dental solutions into their own practice.
Hans Geiselhöringer, President of Nobel Biocare, said: “Where others in the market attempt to imitate, we innovate. With the exclusive showing of the new Nobel Biocare N1 implant system at our upcoming symposium, Nobel Biocare is starting to prepare dental professionals for a new chapter in dental implant care. In Madrid, the future of implant dentistry will be revealed.”
The Nobel Biocare Global Symposium in Madrid will take place at the Madrid Marriott Auditorium Hotel & Conference Center from June 27-29, 2019. Dental professionals who want to know more about the program and how to register for the event should immediately contact their local Nobel Biocare sales representative. Information are also available online at nobelbiocare.com/global-symposia.
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and DTX Studio™) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at six sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.